Recent News & PR

Summary

Message to Participants

N/A

Detailed Information

Liquid Mine Inc. is a company that provides high-precision genetic analysis technology for cancer treatment. It focuses particularly on leukemia, aiming to create the optimal treatment environment for each patient. It promotes the dissemination of cancer genomic medicine using a testing system called MyRD®.

Unfair Advantage & Strengths

N/A

Competitors

N/A

Company Profile

事業カテゴリ

Healthcare / Biotech, DeepTech

本社所在地

Shibuya-ku, Tokyo, Japan

設立日

2019年11月7日

資本金

81,328,625円

Industry Outlook & Trends for Liquid Mine Inc.

Driven by aging populations and rising healthcare costs, the healthcare and biotech market where Liquid Mine Inc. operates is growing globally. Telemedicine, digital health via wearables, AI-driven drug discovery, and gene therapy are advancing rapidly. The industry is shifting from treatment to prevention, increasing demand for highly personalized health solutions like those developed by Liquid Mine Inc..

🔒

VPO Investor Pro Features

You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:

🎬

Elevator & Full Pitch Video

Watch full presentations with English/Japanese subtitles.

📊

AI Quick Report & Valuation

Get AI-driven assessment scores on market, product, and traction.

📅

Priority Challenges & Hiring

Access core corporate bottlenecks and current hiring plans.

📝

Full Transcripts

Read full pitch dialogue in both English and Japanese.

📈

Financials & Exit Strategy

Unlock IPO/M&A timelines and debt/equity plans.

👥

Advisors & Key Members

View internal team details and advisory board configurations.

Create Free Account & View Details

Liquid Mine Inc.